GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Researchers Explore Neuroscience-Inspired Methods for Dynamic Learning in AI Systems

by GOAI
Share To

Researchers have examined the parallels between neuroscience and artificial intelligence (AI) to address challenges in dynamic learning environments. Current AI systems, particularly large language models, typically undergo a process of extensive training on vast datasets, followed by fine-tuning for specific tasks. Once deployed, these systems operate with fixed parameters. This method often requires substantial computational resources and time due to the billions of iterations needed during training.

The study highlights the limitations of this static approach in adapting to changing environments or new information after deployment. Drawing inspiration from neuroscience, researchers are exploring ways to enable AI systems to learn dynamically and continuously without requiring complete retraining. Such advancements could potentially reduce resource demands while improving adaptability in real-time applications. The findings aim to bridge gaps between biological learning mechanisms and artificial systems, offering insights into more efficient AI development strategies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top